Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events ari gnanasakthy represents rti hs recent pro workshop
Webinar: The End of Significance Testing Share on: Thursday, March 28, 2019 Watch the recording The use of statistical significance testing in epidemiological research Null hypothesis significance testing is not dead, but in this webinar, Ken Rothman …
Webinar: Market Access Evidence Roadmaps Share on: Tuesday, June 16, 2020 Watch Recorded Webinar Maximizing Asset Value Through Evidence Generation Planning In the development of new medical products, it is important to generate clinical evidence to …
Webinar: Economic Modelling Challenges in Rare Diseases Share on: Wednesday, February 27, 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a challenge. The limited amount of data available …
… Kingdom Shaun Abeysinghe, PhD, is a Senior Director at RTI-HS. He has over 15 years of experience as a biostatistician … data sets in diverse therapeutic areas. His role at RTI-HS includes planning, executing, and interpreting the …
… Analysis Training Share on: January 10, 2018 Image Join RTI Health Solutions researchers as they teach Budget Impact Analysis. RTI-HS experts Stephanie Earnshaw , Vice President of …
… are higher than those for drugs alone. Researchers at RTI Health Solutions and LivaNova, PLC conducted a study to … Purser, PhD, Associate Director of Health Economics at RTI-HS and lead author of the paper reports, “We found that …
… Collaboration Working at RTI-HS is different—meaningful, highly professional and motivated … in multidisciplinary, integrated teams is a big asset of RTI-HS and makes us unique. For example, after a client call …
… Senior Director of Patient-Centered Outcomes Assessment at RTI-HS. Dr. Brown has more than 20 years of experience in patient … rheumatology, dermatology, and rare diseases. Some of her recent work has been published in the Patient Preference and …
… in the Patient-Centered Outcomes Assessment group with RTI-HS. As an applied social science researcher for the past 9 … in both qualitative and quantitative methods recognized in recent patient-focused drug development guidance authored by …
… the Pharmacoepidemiology and Risk Management group with RTI-HS. Ms. Smith has over 10 years of experience managing public … international collaborative projects, such as her most recent position as the project manager for a phase 2/3 …